Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pha...

FDA Recall #D-0648-2024 — Class II — August 21, 2024

Recall #D-0648-2024 Date: August 21, 2024 Classification: Class II Status: Terminated

Product Description

Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01

Reason for Recall

Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.

Recalling Firm

Lupin Pharmaceuticals Inc. — Baltimore, MD

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4554 bottles

Distribution

USA nationwide.

Code Information

Lot #: F201517, Exp 11/30/2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated